Company Filing History:
Years Active: 1999
Title: Kap Soo Noh: Innovator in Vaccine Development
Introduction
Kap Soo Noh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of vaccine development, particularly in relation to Pseudomonas aeruginosa infections. His innovative work has the potential to impact public health positively.
Latest Patents
Kap Soo Noh holds a patent for a process for preparing a vaccine against Pseudomonas aeruginosa. This vaccine is derived from attenuated strains of Pseudomonas aeruginosa, specifically isolated and purified according to the Fisher-Devlin immunotype. The strains involved in this process include CFCPA 10142 (KCCM 10029), CFCPA 20215 (KCCM 10030), CFCPA 30720 (KCCM 10031), CFCPA 40057 (KCCM 10032), CFCPA 50243 (KCCM 10033), CFCPA 60534 (KCCM 10034), and CFCPA 70018 (KCCM 10035). The vaccine contains cell wall proteins with molecular weights ranging from 10,000 to 100,000, which are non-pathogenic and safe. These proteins exhibit excellent antibody formation capacity and are useful for both vaccine and therapeutic agent preparation.
Career Highlights
Kap Soo Noh is associated with Cheiljedang Corp., where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to combating bacterial infections.
Collaborations
He collaborates with notable colleagues, including Hyun Su Kim and Wan Je Park, who contribute to his research endeavors.
Conclusion
Kap Soo Noh's contributions to vaccine development highlight his role as an innovator in the field. His work on Pseudomonas aeruginosa vaccines demonstrates the potential for significant advancements in medical science.